Loading company…
Riskpilot
← Back to search
Sign in
Get full access
AGOPRENE AS
AS
Active
Org 933977439
Gulliveien 63, 3157 Barkåker
Other manufacturing n.e.c. · NACE 3299
Est. 2024
5 employees
Watchlist
Share
Overview
Financials
People & ownership
Related companies
Revenue 2024
NOK 0
EBITDA margin
—
Equity ratio
100.0%
Financial strength
Net profit 2024
NOK -1K
5 employees
EBITDA — year on year
NOK millions
0M
-0M
-1M
-1M
-1M
0M
2024
Key figures
Annual report 2024
Revenue
NOK 0
—
EBITDA
NOK -1K
—
Net profit
NOK -1K
—
Total assets
NOK 21K
—
Equity
NOK 21K
—
Employees
5
—
Company information
Legal name
AGOPRENE AS
Org number
933977439
Legal form
Aksjeselskap
NACE code
3299 · Other manufacturing n.e.c.
Founded
27. august 2024
Share capital
NOK 50 047
Employees
5 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Company purpose
Utvikling og produksjon av skumgummi fra tang og tare.
Contact
Address
Gulliveien 63, 3157 Barkåker
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
Visit risika.com
Explore
Companies in Other manufacturing n.e.c.
Companies in Tønsberg
All Norway companies
Revenue
NOK millions
0M
0M
1M
1M
1M
0M
2024
EBITDA
NOK millions
0M
0M
1M
1M
1M
0M
2024
Income statement
NOK thousands
Item
2024
Revenue
0
Staff expenses
−0
EBITDA
−1
Depreciation & amort.
−0
EBIT
−1
Net financials
0
Profit before tax
−1
Tax
−0
Net profit
−1
Balance sheet
NOK thousands
Item
2024
Total assets
21
Equity
21
Long-term debt
0
Short-term debt
0
Total debt
0
Financial ratios
5-year trend
EBITDA margin
-105000.0%
This company
15.8%
Market median
-664657% vs market
2024
2024
Equity ratio
100.0%
This company
38.2%
Market median
+162% vs market
2024
2024
Return on equity
-4.9%
This company
18.4%
Market median
-127% vs market
2024
2024
Net profit margin
-105000.0%
This company
8.1%
Market median
-1296396% vs market
2024
2024
Asset turnover
0.00×
This company
1.12×
Market median
-100% vs market
2024
2024
Debt / equity
0.00×
This company
0.62×
Market median
+100% vs market
2024
2024
Annual reports & filings
Annual report 2024
Filed via Brønnøysundsregistrene · Period 2024-06-04 – 2024-12-31
View
PDF
Management
Actively employed in the business
No data on file.
Board of directors
Non-executive oversight
Name
Role
Member since
Current (2)
FA
Fredrik Aas
Chairman
2025
CN
Celine Natalie Nyrerød Sandberg
Chairman
2024
Shareholders
As of last annual report
Shareholder
Type
Ownership
Votes
Since
Cnns Holding As
Company
100%
100%
2024
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive.
Learn more
.
Company hierarchy
Cnns Holding As
AGOPRENE AS
(this company)
Board network connections
Board members of AGOPRENE AS also hold positions in
0
other companies.
Person
Role here
Other companies
Fredrik Aas
Chairman
0 companies
Celine Natalie Nyrerød Sandberg
Chairman
0 companies